A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects
Clinical trial NCT04536337 · COMPLETED
Trial details
- NCT number
- NCT04536337
- Sponsor
- Aligos Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-22
- Primary completion
- 2025-06-16
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.